Gepirone
| Gepirone | |
|---|---|
| Gepirone.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Gepirone is a pharmaceutical compound that belongs to the class of azapirones, which are known for their anxiolytic and antidepressant properties. It is primarily used in the treatment of anxiety disorders and depression.
Pharmacology[edit]
Gepirone functions as a selective partial agonist of the 5-HT1A receptor, a subtype of the serotonin receptor. This action is believed to contribute to its anxiolytic and antidepressant effects. Unlike traditional benzodiazepines, gepirone does not exhibit sedative or muscle relaxant properties, making it a preferable option for patients who need to avoid these side effects.
Mechanism of Action[edit]
Gepirone's mechanism of action involves modulation of the serotonergic system. By partially activating the 5-HT1A receptors, gepirone enhances serotonergic neurotransmission, which is associated with mood regulation and anxiety reduction. This mechanism is similar to that of other azapirones, such as buspirone.
Clinical Use[edit]
Gepirone is indicated for the treatment of generalized anxiety disorder (GAD) and major depressive disorder (MDD). It is particularly useful in patients who are sensitive to the side effects of other anxiolytics or antidepressants. Gepirone is typically administered orally, and its dosage is adjusted based on the patient's response and tolerance.
Side Effects[edit]
Common side effects of gepirone include dizziness, nausea, headache, and insomnia. These side effects are generally mild and tend to diminish with continued use. Unlike benzodiazepines, gepirone does not cause dependency or withdrawal symptoms, making it a safer long-term treatment option.
Development and Approval[edit]
Gepirone was developed as part of a class of drugs aimed at providing anxiolytic and antidepressant effects without the drawbacks of traditional medications. Although it has shown promise in clinical trials, its approval status varies by country, and it may not be available in all markets.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
